Unknown

Dataset Information

0

[PDMR] [cell line] [BL0479-F1894-PDC] Urothelial Carcinoma

ABSTRACT:

SUBMITTER:  

PROVIDER: S-CMO4211 | biostudies-other |

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
| S-EPMC5635424 | biostudies-literature
Unknown Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy.
| S-EPMC9205436 | biostudies-literature
Unknown First- and second-line therapy for metastatic urothelial carcinoma of the bladder.
| S-EPMC3031362 | biostudies-literature
Unknown HERV-K and LINE-1 DNA Methylation and Reexpression in Urothelial Carcinoma.
| S-EPMC3783855 | biostudies-literature
Unknown Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey.
| S-EPMC12558748 | biostudies-literature
Unknown Protein Profiling of Bladder Urothelial Cell Carcinoma.
| S-EPMC5023150 | biostudies-literature
Unknown Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma.
| S-EPMC5715265 | biostudies-literature
Unknown Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma.
| S-EPMC9460895 | biostudies-literature
Unknown Meloxicam in Combination with Mitoxantrone or Vinblastine as First-Line Treatment for Non-Resectable Urothelial Cell Carcinoma in Dogs.
| S-EPMC10458788 | biostudies-literature
Transcriptomics Transcription profiling of human pDC cell line
2008-10-26 | E-GEOD-12507 | biostudies-arrayexpress